Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Oncogene

• Publication date

  2005-12-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1208985PMID 16170371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells.

  2005cited by this paper
• Cell Surface and Transcriptional Characterization of Human Adipose‐Derived Adherent Stromal (hADAS) Cells

  2005cited by this paper
• Jun proteins modulate the ovary-specific promoter of aromatase gene in ovarian granulosa cells via a cAMP-responsive element

  2005cited by this paper
• The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters.

  2003cited by this paper
• Loss of Bard1, the Heterodimeric Partner of the Brca1 Tumor Suppressor, Results in Early Embryonic Lethality and Chromosomal Instability

  2003cited by this paper
• The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair.

  2003cited by this paper
• Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.

  2003cited by this paper
• Cancer susceptibility and the functions of BRCA1 and BRCA2.

  2002cited by this paper
• Development and validation of a new monoclonal antibody to mammalian aromatase.

  2002cited by this paper
• Review Cancer Susceptibility and the Functions of BRCA1 and BRCA2

  2002cited by this paper
• Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers.

  2002cited by this paper
• The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

  2002cited by this paper
• Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

  2002cited by this paper
• JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.

  2002cited by this paper
• Aromatase--a brief overview.

  2002cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

  2001cited by this paper
• Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development

  2001cited by this paper
• Modulation of aromatase expression in human breast tissue.

  2001cited by this paper
• New signaling pathways for hormones and cyclic adenosine 3',5'-monophosphate action in endocrine cells.

  2001cited by this paper
• Minireview: Aromatase and the Regulation of Estrogen Biosynthesis-Some New Perspectives.

  2001cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society

  2000influential reference
• Aromatase overexpression and breast hyperplasia, an in vivo model--continued overexpression of aromatase is sufficient to maintain hyperplasia without circulating estrogens, and aromatase inhibitors abrogate these preneoplastic changes in mammary glands.

  1999cited by this paper
• Endogenous hormones and the aetiology of breast cancer

  1999cited by this paper
• Identification and characterization of a cAMP-responsive element in the region upstream from promoter 1.3 of the human aromatase gene.

  1999cited by this paper
• Intratumoral aromatase in human breast, endometrial, and ovarian malignancies.

  1998cited by this paper
• Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.

  1997cited by this paper
• Brca1 is expressed independently of hormonal stimulation in the mouse ovary.

  1997cited by this paper
• Mechanisms of the actions of aromatase inhibitors 4-hydroxyandrostenedione, fadrozole, and aminoglutethimide on aromatase in JEG-3 cell culture.

  1997cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Hormonal control of gene expression in the ovary.

  1994cited by this paper

• Depletion of BRCA1 Potentiates Progestin-Induced Cytoskeletal Changes in an Ovarian Cancer Cell Model

  2026cites this paper
• Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer

  2024cites this paper
• The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers

  2023cites this paper
• Breast cancers arising in subjects with germline BRCA1 or BRCA2 mutations: different biological and clinical entities with potentially diverse therapeutic opportunities.

  2023cites this paper
• Mechanistic Effects of Estrogens on Breast Cancer

  2022cites this paper
• Cyclin-dependent kinase 4 and 6 inhibitors at the crossroads: the combinational therapeutic strategies in breast cancer—a narrative review

  2021cites this paper
• Mechanism of Action and Clinical Efficacy of CDK4/6 Inhibitors in BRCA-Mutated, Estrogen Receptor-Positive Breast Cancers: Case Report and Literature Review

  2019cites this paper
• BRCA1 and Breast Cancer: a Review of the Underlying Mechanisms Resulting in the Tissue-Specific Tumorigenesis in Mutation Carriers

  2019cites this paper
• A molecular basis for Estrogen Receptor- α deficiency in BRCA1-linked breast cancer

  2019cites this paper
• CRISPR/Cas9-Mediated BRCA1 Knockdown Adipose Stem Cells Promote Breast Cancer Progression

  2019cites this paper
• Tumor Cell-Independent Estrogen Signaling Drives Disease Progression through Mobilization of Myeloid-Derived Suppressor Cells.

  2017cites this paper
• NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of BRCA1-Mutated Breast Cancer

  2017cites this paper
• Detection and evaluation of estrogen DNA‐adducts and their carcinogenic effects in cultured human cells using biotinylated estradiol

  2017cites this paper
• Dysregulation of Aromatase in Breast, Endometrial, and Ovarian Cancers: An Overview of Therapeutic Strategies.

  2016cites this paper
• POTENTIAL CONSEQUENCES OF THE BRCA 1 MUTATION CARRIER STATE ON ESTROGEN RESPONSIVE ORGANS

  2016cites this paper
• CyTRANSFINDER: a Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction

  2016cites this paper
• The Role of Steroid Hormones, GREB1, and Reproductive Status in Ovarian Cancer Progression

  2016cites this paper
• Effects of BRCA1 Knockdown on CYP19a1/Aromatase and Steroid Receptor Expression in Ovarian and Tubal Cells

  2015cites this paper
• Role of Reactive Oxygen Species in Estrogen Dependant Breast Cancer Complication.

  2015cites this paper
• Pathogenesis of serous, extra-uterine Müllerian epithelial cancer and therapeutic implications.

  2015cites this paper
• Genetics of androgen metabolism in women with infertility and hypoandrogenism

  2015cites this paper
• Prospective multicenter cohort study of estrogen and insulin-like growth factor system in BRCA mutation carriers

  2015cites this paper
• Granulosa Cell-Specific Brca1 Loss Alone or Combined with Trp53 Haploinsufficiency and Transgenic FSH Expression Fails to Induce Ovarian Tumors

  2015cites this paper
• BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.

  2014cites this paper
• The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women

  2014cites this paper
• BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?

  2014cites this paper
• Hormone responsive breast cancer and BRCA1 mutation: mechanism, regulation and iron-mediated effects.

  2014cites this paper
• Regulation of adipose oestrogen output by mechanical stress

  2013cites this paper
• DHEA metabolites activate estrogen receptors alpha and beta.

  2013cites this paper
• Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells

  2013cites this paper
• Computational modelling of bovine ovarian follicle development

  2013cites this paper
• Mouse models of BRCA1 and their application to breast cancer research

  2013cites this paper
• ROLE OF ESTROGEN IN FAMILIAL BREAST CANCER

  2013cites this paper
• Baseline E2 levels are higher in BRCA2 mutation carriers: a potential target for prevention?

  2013cites this paper
• Ring Finger Nuclear Factor RNF168 Is Important for Defects in Homologous Recombination Caused by Loss of the Breast Cancer Susceptibility Factor BRCA1*

  2012cites this paper
• Circadian modulation of the estrogen receptor alpha transcription

  2012cites this paper
• Pioglitazone, a PPARγ Agonist, Suppresses CYP19 Transcription: Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA1

  2012cites this paper
• POTENTIAL CONSEQUENCES OF THE BRCA1 MUTATION CARRIER STATE ON ESTROGEN RESPONSIVE ORGANS

  2012cites this paper
• Pioglitazone , a PPAR g Agonist , Suppresses CYP 19 Transcription : Evidence for Involvement of 15-Hydroxyprostaglandin Dehydrogenase and BRCA 1

  2012cites this paper
• PPARγ Agonists Target Aromatase Via Both PGE2 and BRCA1

  2012cites this paper
• A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer

  2012cites this paper
• Technical challenges and limitations of current mouse models of ovarian cancer

  2012cites this paper
• Hormonal mechanisms underlying the relationship between obesity and breast cancer.

  2011cites this paper
• The Prostaglandin Transporter Regulates Adipogenesis and Aromatase Transcription

  2011cites this paper
• Gerosuppressant Metformin: less is more

  2011cites this paper
• Isolated and combined action of tamoxifen and metformin in wild-type, tamoxifen-resistant, and estrogen-deprived MCF-7 cells

  2011cites this paper
• BRCA1/BARD1 complex interacts with steroidogenic factor 1--A potential mechanism for regulation of aromatase expression by BRCA1.

  2011cites this paper
• Mechanical phenotype is important for stromal aromatase expression.

  2011cites this paper
• The Effects of the Female Reproductive Hormones on Ovarian Cancer Initiation and Progression in a Transgenic Mouse Model of the Disease

  2011cites this paper
• Influence des hormones stéroïdes et potentiel préventif d'un antiprogestatif, l'ulpristal acétate, dans la tumorigenèse liée à la mutation du gène BRCA1

  2011cites this paper
• CHAPTER 17 – Physiology and Pathology of the Female Reproductive Axis

  2011cites this paper
• Investigating the Combined Effect of Brca1 Loss and Estradiol Increase on Ovarian Tumourigenesis

  2011influential citation
• Molecular biomarkers associated with mutant BRCAl breast cancer patients

  2011cites this paper
• Cell density is a critical determinant of aromatase expression in adipose stromal cells.

  2010cites this paper
• Changes in the mouse estrus cycle in response to BRCA1 inactivation suggest a potential link between risk factors for familial and sporadic ovarian cancer.

  2010cites this paper
• Study of inflammatory signalling in epithelial ovarian cancer and the normal human mesothelium

  2010cites this paper
• Cell density-dependent transcriptional activation of endocrine-related genes in human adipose tissue-derived stem cells.

  2010cites this paper
• ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approaches.

  2009cites this paper
• BRCA1 Cross-Talk with Hormone Receptors.

  2009cites this paper
• Aromatase, CYP1B1 and Fatty Acid Synthase Expression in Breast Tumors of BRCA1 Mutation Carriers

  2009influential citation
• Induction of Ovarian Leiomyosarcomas in Mice by Conditional Inactivation of Brca1 and p53

  2009cites this paper
• BRCA1 and BRCA2: Role in the DNA Damage Response, Cancer Formation and Treatment

  2009cites this paper
• Hormonal and Molecular Regulation of the Cytochrome P450 Aromatase Gene Expression in the Ovary

  2009cites this paper
• History of aromatase: saga of an important biological mediator and therapeutic target.

  2009cites this paper
• Regulation of Aromatase Expression in Breast Cancer Tissue

  2009cites this paper
• Aromatase expression is increased in BRCA1 mutation carriers

  2009cites this paper
• IKKbeta mediates cell shape-induced aromatase expression and estrogen biosynthesis in adipose stromal cells.

  2009cites this paper
• Aromatase expression in the ovary: hormonal and molecular regulation.

  2008cites this paper
• Decreased BRCA1 Confers Tamoxifen Resistance in Breast Cancer Cells by Altering Estrogen Receptor-Coregulator Interactions

  2008cites this paper
• A Role of CREB in BRCA1 Constitutive Promoter Activity and Aromatase Basal Expression

  2008cites this paper
• Sporadic epithelial ovarian cancer: clinical relevance of BRCA1 inhibition in the DNA damage and repair pathway.

  2008cites this paper
• Endocrinology of the wild and mutant BRCA1 gene and types of hormonal carcinogenesis.

  2008influential citation
• BRCA1, Hormone, and Tissue-Specific Tumor Suppression

  2008cites this paper
• BRCA1-induced ovarian oncogenesis.

  2008cites this paper
• EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.

  2008cites this paper
• Long-term BRCA1 down-regulation by small hairpin RNAs targeting the 3' untranslated region.

  2008cites this paper
• EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells

  2008cites this paper
• Enhanced expression of aromatase in p53-inactivated mammary epithelial cells.

  2008influential citation
• Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors

  2008cites this paper
• Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.

  2007influential citation
• A role of estrogen/ERα signaling in BRCA1-associated tissue-specific tumor formation

  2007influential citation
• Conditional inactivation of the BRCA1 tumour suppressor gene in the mouse ovarian surface epithelium in vitro and in vivo

  2007cites this paper
• Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.

  2007cites this paper
• Aromatase inhibitors in ovarian cancer: is there a role?

  2007cites this paper
• A PERSPECTIVE FROM THE TUMOR MICROENVIRONMENT

  2007cites this paper
• Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.

  2007cites this paper
• BRCA1 in initiation, invasion, and metastasis of breast cancer: a perspective from the tumor microenvironment

  2007cites this paper
• Molecular Basis for Estrogen Receptor α Deficiency in BRCA1-Linked Breast Cancer

  2007cites this paper
• Mechanism of Ovarian Epithelial Tumor Predisposition in Individuals Carrying Germline BRCA1 Mutations

  2006cites this paper
• BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.

  2006cites this paper
• Review of: BRCA1 and cyclin D1: gate keepers in hormone responsive tissues?

  2006cites this paper
• Hyperplasia and Spontaneous Tumor Development in the Gynecologic System in Mice Lacking the BRCA1-Δ11 Isoform

  2006cites this paper
• Basic science: (December 2005)

  2006cites this paper